SM
XERS icon

SG3 Management’s Xeris Biopharma Holdings XERS Stock Holding History

SG3 Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,000
Closed -$147K – 1403
2021
Q4 		$147K Buy
+50,000
New +$108K ﹤0.01% 859
2021
Q3 		– Sell
-63,000
Closed -$256K – 1279
2021
Q2 		$256K Buy
63,000
+13,000
+26% +$49.6K 0.01% 775
2021
Q1 		$226K Hold
50,000
– – 0.01% 941
2020
Q4 		$246K Buy
50,000
+20,000
+67% +$100K ﹤0.01% 842
2020
Q3 		$178K Buy
+30,000
New +$120K 0.01% 742

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return